You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 20, 2025

Details for Patent: 11,135,215


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,135,215
Title:Opioid formulations
Abstract:A depot precursor formulation comprising:
Inventor(s):Tiberg Fredrik, Harwigsson Ian, Johnsson Markus
Assignee:Camurus AB
Application Number:US17142723
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,135,215

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and overall value. This article will delve into the detailed analysis of the scope and claims of United States Patent 11,135,215, using various tools and methodologies.

Understanding Patent Claims

Patent claims are the most critical part of a patent application, as they define the scope of the invention and what is protected by the patent[3].

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are typically broader and more comprehensive.
  • Dependent Claims: These claims refer back to an independent claim and further limit the scope of the invention.

Analyzing the Scope of Patent 11,135,215

Claim Language and Metrics

To measure the scope of a patent, simple metrics such as independent claim length and independent claim count can be used. These metrics can provide insights into the breadth and clarity of the patent claims[5].

  • Independent Claim Length: Longer independent claims often indicate a more detailed and specific invention, which can be narrower in scope.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, as each claim may cover different aspects of the invention.

Claim Coverage Matrix

A Claim Coverage Matrix is a useful tool for categorizing patents by claims and scope concepts. This matrix helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Patent Landscape Analysis

Tracking Patents by Claims and Scope Concepts

To understand the patent landscape, it is essential to categorize patents not only by claims but also by overarching scope concepts. This approach allows for filtering, searching, and accurately analyzing large numbers of patent claims concurrently[3].

Claim Charts

Claim charts generated by software like ClaimScape® can help in reviewing patent coverage with engineers, scientists, and management. These charts can determine whether a particular scope concept is applicable to a target product or method, highlighting gaps in current coverage and future design opportunities[3].

Tools for Patent Search and Analysis

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching existing patents and published patent applications. This tool provides enhanced access to prior art and improves the overall patent searching process[4].

Global Dossier

The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related applications[4].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application, enabling a single-point access to citation data and facilitating a more integrated global patent system[4].

Legal and Policy Considerations

Obviousness-Type Double Patenting (ODP)

In cases where multiple patents are derived from the same application, ODP analysis is crucial to prevent an inventor from securing a second, later-expiring patent for an invention covered by a previously granted patent. This is particularly relevant when patents have different terms due to Patent Term Adjustments (PTA)[1].

Patent Term Adjustments and Extensions

Understanding the differences between PTA and Patent Term Extensions (PTE) is vital. While PTE can extend the term of a patent beyond its original expiration date due to regulatory review, PTA adjusts the term due to USPTO delays during prosecution. However, PTA does not extend the term beyond the date specified in a terminal disclaimer[1].

Practical Applications and Stakeholder Input

Small Claims Patent Court Study

The Administrative Conference of the United States (ACUS) has conducted studies on the feasibility of a small claims patent court, engaging a wide range of stakeholders including academic experts and legal practitioners. Such initiatives highlight the need for accessible and efficient dispute resolution mechanisms in patent law[2].

Key Takeaways

  • Claim Analysis: Understanding the language and structure of patent claims is essential for determining the scope of protection.
  • Patent Landscape: Using tools like Claim Coverage Matrices and Claim Charts helps in identifying gaps and opportunities in patent coverage.
  • Legal Considerations: ODP analysis and understanding PTA and PTE are critical for managing patent terms and preventing invalidation.
  • Stakeholder Engagement: Input from various stakeholders is vital for improving patent law and procedures.

FAQs

Q: What is the significance of independent claims in a patent? A: Independent claims define the invention without reference to other claims and are typically broader and more comprehensive.

Q: How can the scope of a patent be measured? A: Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent.

Q: What is the purpose of a Claim Coverage Matrix? A: A Claim Coverage Matrix helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist.

Q: What is the difference between PTA and PTE? A: PTA adjusts the patent term due to USPTO delays during prosecution, while PTE extends the term due to regulatory review.

Q: Why is ODP analysis important? A: ODP analysis prevents an inventor from securing a second, later-expiring patent for an invention covered by a previously granted patent.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States[2]
  3. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.[3]
  4. Search for Patents - United States Patent and Trademark Office[4]
  5. Patent Claims and Patent Scope - SSRN[5]

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,135,215

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-001 May 23, 2023 RX Yes No 11,135,215 ⤷  Try for Free Y ⤷  Try for Free
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-002 May 23, 2023 RX Yes No 11,135,215 ⤷  Try for Free Y ⤷  Try for Free
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-003 May 23, 2023 RX Yes No 11,135,215 ⤷  Try for Free Y ⤷  Try for Free
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-004 May 23, 2023 RX Yes No 11,135,215 ⤷  Try for Free Y ⤷  Try for Free
Braeburn BRIXADI buprenorphine SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS 210136-005 May 23, 2023 RX Yes No 11,135,215 ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,135,215

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E401054 ⤷  Try for Free
Austria E462409 ⤷  Try for Free
Austria E501710 ⤷  Try for Free
Australia 2005249274 ⤷  Try for Free
Australia 2005324794 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.